146 related articles for article (PubMed ID: 15713692)
1. The degree of potassium channel blockade and the risk of torsade de pointes: the truth, nothing but the truth, but not the whole truth.
Viskin S; Rosovski U
Eur Heart J; 2005 Mar; 26(6):536-7. PubMed ID: 15713692
[No Abstract] [Full Text] [Related]
2. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
Skanes AC; Morton BC; Green MS; Tang AS
Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
[TBL] [Abstract][Full Text] [Related]
3. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome.
Wegener FT; Ehrlich JR; Hohnloser SH
Europace; 2008 Jan; 10(1):112-3. PubMed ID: 18006559
[No Abstract] [Full Text] [Related]
4. Torsade de pointes induced by amiodarone in a patient with heart failure.
Jhuo SJ; Tang WH; Lai WT; Lee KT
Kaohsiung J Med Sci; 2014 Feb; 30(2):108-9. PubMed ID: 24444543
[No Abstract] [Full Text] [Related]
5. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
Shah SA; Kluger J; White CM
Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
[TBL] [Abstract][Full Text] [Related]
6. [Torsade de pointes during anti-arrhythmia treatment with amiodarone].
Schlienger RG; Haefeli WE; Lüscher TF
Schweiz Rundsch Med Prax; 1993 Feb; 82(6):173-5. PubMed ID: 7679520
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in the proarrhythmic potential of QT-prolonging drugs.
Wolbrette D
Curr Womens Health Rep; 2002 Apr; 2(2):105-9. PubMed ID: 12116598
[TBL] [Abstract][Full Text] [Related]
8. [Amiodarone-induced torsade de pointes--five case reports].
Kukla P; Słowiak-Lewińska T
Kardiol Pol; 2004 Apr; 60(4):365-70; discussion 371. PubMed ID: 15226788
[TBL] [Abstract][Full Text] [Related]
9. Amiodarone-associated "torsade de pointes". Relevance of concomitant cardiovascular medication in a patient with atrial fibrillation and structural heart disease.
Schrickel J; Bielik H; Yang A; Schwab JO; Shlevkov N; Schimpf R; Lüderitz B; Lewalter T
Z Kardiol; 2003 Oct; 92(10):889-92. PubMed ID: 14579055
[TBL] [Abstract][Full Text] [Related]
10. [Proarrhythmia caused by amiodarone].
Pagano L; Della Monica R; Malinconico M
Minerva Cardioangiol; 2001 Dec; 49(6):421-8. PubMed ID: 11733739
[TBL] [Abstract][Full Text] [Related]
11. Amiodarone-induced torsade de pointes in a child with dilated cardiomyopathy.
Silvetti MS; Drago F; Bevilacqua M; Ragonese P
Ital Heart J; 2001 Mar; 2(3):231-6. PubMed ID: 11305536
[TBL] [Abstract][Full Text] [Related]
12. Amiodarone--avoid the danger of torsade de pointes.
Foley P; Kalra P; Andrews N
Resuscitation; 2008 Jan; 76(1):137-41. PubMed ID: 17716804
[TBL] [Abstract][Full Text] [Related]
13. Torsade de pointes induced by short-term oral amiodarone therapy.
Lim HE; Pak HN; Ahn JC; Song WH; Kim YH
Europace; 2006 Dec; 8(12):1051-3. PubMed ID: 17148550
[TBL] [Abstract][Full Text] [Related]
14. "Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval.
Di Micoli A; Zambruni A; Bracci E; Benazzi B; Zappoli P; Berzigotti A; Zoli M; Bernardi M; Trevisani F
Dig Liver Dis; 2009 Jul; 41(7):535-8. PubMed ID: 18294935
[TBL] [Abstract][Full Text] [Related]
15. "Torsade de pointes" in patients with structural heart disease and atrial fibrillation treated with amiodarone, beta-blockers, and digitalis.
Schrickel JW; Schwab JO; Yang A; Bitzen A; Lüderitz B; Lewalter T
Pacing Clin Electrophysiol; 2006 Apr; 29(4):363-6. PubMed ID: 16650263
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced long QT syndrome and torsade de pointes.
Morissette P; Hreiche R; Turgeon J
Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
[TBL] [Abstract][Full Text] [Related]
17. Amiodarone versus sotalol for atrial fibrillation.
Zimetbaum PJ; Josephson ME
N Engl J Med; 2005 Aug; 353(6):627-30; author reply 627-30. PubMed ID: 16094764
[No Abstract] [Full Text] [Related]
18. [Torsade de pointes secondary to amiodarone overdose].
Lee Hwang D; Barriales Alvarez V; Lasa Larraya G; Rondán Murillo J
Med Clin (Barc); 2004 Jun; 123(4):156-7. PubMed ID: 15274812
[No Abstract] [Full Text] [Related]
19. Serious QT interval prolongation with ranolazine and amiodarone.
Tarapués M; Cereza G; Arellano AL; Montané E; Figueras A
Int J Cardiol; 2014 Mar; 172(1):e60-1. PubMed ID: 24424337
[No Abstract] [Full Text] [Related]
20. Beat-to-beat variability of repolarization differentiates the extent of torsadogenic potential of multi ion channel-blockers bepridil and amiodarone.
Takahara A; Nakamura Y; Sugiyama A
Eur J Pharmacol; 2008 Oct; 596(1-3):127-31. PubMed ID: 18786527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
